
Licensed, profitable German medical cannabis importer & wholesaler for sale with €9M/yr revenue
Fully licensed & profitable German medical cannabis distributor offers an integrated, EU-GDP compliant platform for immediate market access and a gateway to EU-GMP processing, with €9M revenue in 2025 with €10.8M projected in 2026
Listing ID:
42249812560
Licence(s) Held:
Registered Dealer of Pharmaceutical Ingredients, MedCan permit and EU-GDP Wholesaler. Medical Import Licence. EU-GMP manufacturing certification in progress.

Seeking outright divestiture of the licences and going concern business for €4.5 million o.b.o
Listing Details:
This is a fully operational, profitable medical cannabis importer & wholesaler with established distribution across the German market, the single largest and most valuable medical cannabis market in Europe.
The company is a solid revenue-generator, with sales of €9 million in 2025, and €10.8 Million in revenue projected for 2026.
The platform provides direct, regulatory-compliant market access, leveraging established EU-GDP and EU-GMP supply chains and a trusted network of 40 global suppliers for broad-based product sourcing.
The company distributes a diverse product portfolio (+50 products across +35 strains), including its own proprietary brands.
The company is actively pending EU-GMP manufacturing certification which will provide a clear, de-risked pathway to internal processing and product manufacturing, allowing the capture of higher-margin activities.
The company is led by an experienced management team with deep roots in the German pharmaceutical and pharmacy markets.
The R&D pipeline focuses on high-value product innovation, including access to an innovative lozenge formulation and specialized oral administration solutions, securing a future competitive advantage.
The business is highly scalable, successfully managing high-volume sales (over 2.5 tonnes annually) with a minimal workforce (15 FTEs), ready for increased throughput upon capital injection.
The acquisition secures access to a patented purification technology, ensuring a proprietary, cost-efficient supply chain of pharmaceutical-grade, EU-GMP certified product starting in 2026.
This opportunity is ideal for Global Cannabis Operators, Healthcare/Pharma Players, and Investment Firms seeking immediate, de-risked entry and a high-growth platform within the regulated German and European medical cannabis markets.
42249812560
NEW CANNABIS BUSINESSES FOR SALE
See the latest cannabis business listings on the market including dispensaries, cultivation facilities, greenhouses, labs, and more. If you're looking to invest, acquire, or expand, these business opportunities provide the perfect starting point to grow your footprint in the cannabis industry.
56136991370
~32,000 sq. ft. EU-GMP Designed Cannabis & Pharmaceutical Processing Facility for Sale in Germany

Pre-revenue, fully permitted German manufacturing asset offering strategic buyers a turnkey EU-GMP designed production facility with advanced cleanroom infrastructure and pharmaceutical-grade capabilities positioned to capture the emerging European regulated cannabis and specialty medicines market.
8814852867
~4,000 ft.² turnkey, owned, SK-based licensed craft cultivator and processor for $700k (including real estate)!

~4,000 ft.² indoor, standalone and owned micro-cultivation and processing facility situated on 1.01 acres in Saskatchewan. The sale includes the operating company, real estate, unencumbered equipment, established brands, genetics and qualifying inventory for $700K OBO.
55606342051
Fully Licensed German Medical Cannabis Wholesaler & Importer with EU-GMP warehouse for 500k EUR

An exceptional opportunity to acquire 100% of an established German GmbH specifically structured for the high-growth medical cannabis sector. The entity offers a lean, highly scalable infrastructure with all critical operational pillars—including a licensed packing/storage warehouse, fully verified GMP/GDP compliance, strategic supply chain partnerships, and advanced quality technology—positioned for immediate market acceleration.
